Home › Companies › Biotechnology, Genetics, Health Care, Medical, Therapeutics › Kelonia Therapeutics
Kelonia Therapeutics
Kelonia Therapeutics is developing a new wave of genetic medicines using its next-generation vivo gene delivery platform.
Kelonia Therapeutics is active in the biotechnology, genetics, health care, medical, therapeutics space based in Greater Boston Area, East Coast, New England, Northeastern US, founded in 2017.
As a business in biotechnology, genetics, health care, medical, therapeutics, Kelonia Therapeutics is listed here with the public details available about it.
Greater Boston Area, East Coast, New England, Northeastern US is where the company is located.
Directory data places it at the Series_A stage.
Recorded headcount: c_00011_00050 employees.
Public records show total funding of about $50M.
| Sector | Biotechnology, Genetics, Health Care, Medical, Therapeutics |
|---|---|
| Headquarters | Greater Boston Area, East Coast, New England, Northeastern US |
| Founded | 2017 |
| Employees | c_00011_00050 |
| Stage | series_a |
| Total funding | $50,000,000 |
Website: keloniatx.com
Browse related
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account